TORBAYPHARMA Trademark
Trademark Overview
On Monday, June 3, 2024, a trademark application was filed for TORBAYPHARMA with the United States Patent and Trademark Office. The USPTO has given the TORBAYPHARMA trademark a serial number of 79405805. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, July 8, 2025. This trademark is owned by Torbay Pharmaceuticals Limited. The TORBAYPHARMA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; injectable pharmaceuticals for the treatment of relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; drug delivery agents in the form of sterilized generic injectables that facilitate the delivery of pharmaceutical preparations.
General Information
| Serial Number | 79405805 |
| Word Mark | TORBAYPHARMA |
| Filing Date | Monday, June 3, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Tuesday, July 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the stylized wording "TORBAYPHARMA" to the right of a design created from three interconnected six-sided polygons, arranged vertically. |
| Goods and Services | Pharmaceutical preparations and substances for relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; injectable pharmaceuticals for the treatment of relief of pain, anaesthesia, acute hypotension, nutritional deficiency, eclampsia, pre-eclampsia and ventricular failure; drug delivery agents in the form of sterilized generic injectables that facilitate the delivery of pharmaceutical preparations. |
| Pseudo Mark | TORBAY PHARMA |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 3, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Torbay Pharmaceuticals Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, October 3, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, October 7, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 7, 2024 | APPLICATION FILING RECEIPT MAILED |
| Saturday, December 14, 2024 | ASSIGNED TO EXAMINER |
| Friday, December 27, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, January 27, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, January 27, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, December 26, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, February 15, 2025 | REFUSAL PROCESSED BY IB |
| Monday, July 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 7, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 8, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
